These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 350391)

  • 21. Phase II study of ftorafur in previously untreated and treated patients with advanced colorectal cancer.
    Schutt AJ; Hahn RG; Moertel CG; O'Connell MJ; Rubin J; Creagan ET
    Cancer Treat Rep; 1983 May; 67(5):505-6. PubMed ID: 6406062
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 23. Vindesine in the treatment of advanced colorectal cancer: a phase II study.
    Diaz-Rubio E; Martin-Jimenez M
    Cancer Treat Rep; 1984 Mar; 68(3):555-6. PubMed ID: 6704985
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
    Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
    Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of N-methylformamide in patients with advanced colorectal cancer.
    Tchekmedyian NS; Kaplan RS; Eisenberger M; Abrams J; Van Echo D
    Cancer Treat Rep; 1987 May; 71(5):541-2. PubMed ID: 3567980
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II study of hycanthone in patients with advanced colorectal carcinoma.
    Schutt AJ; Dalton RJ; Kovach JS; Moertel CG; O'Connell MJ
    Cancer Treat Rep; 1983 Jun; 67(6):593-4. PubMed ID: 6861166
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase II study of tiazofurin in colorectal cancer: a National Cancer Institute of Canada Study.
    Maroun JA; Eisenhauer E; Cripps C; Maksymiuk A
    Cancer Treat Rep; 1987 Dec; 71(12):1297-8. PubMed ID: 3690542
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II study of sequential methotrexate and 5-FU combination in the treatment of advanced colorectal cancer.
    Canobbio L; Nobile MT; Ardizzoni A; Tatarek R; Rosso R
    Cancer Treat Rep; 1986 Mar; 70(3):419-20. PubMed ID: 3955557
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II trials of the single agents baker's antifol, diaziquone, and epirubicin in advanced pancreatic cancer. Gastrointestinal Tumor Study Group.
    Cancer Treat Rep; 1987 Sep; 71(9):865-7. PubMed ID: 3476203
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II clinical trial of ftorafur in 5-fluorouracil-refractory colorectal cancer.
    Buroker T; Miller A; Baker L; McKenzie M; Samson M; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1579-80. PubMed ID: 336199
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II trial of bisantrene in advanced colorectal carcinoma.
    Ahmed T; Kemeny NE; Michaelson RA; Harper HD
    Cancer Treat Rep; 1983 Mar; 67(3):307-8. PubMed ID: 6831479
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase II study of cytosine arabinoside in advanced large bowel cancer.
    Cullinan SA; O'Connell MJ; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ; Frytak S; Rubin J
    Cancer Treat Rep; 1977 Dec; 61(9):1725-6. PubMed ID: 340037
    [No Abstract]   [Full Text] [Related]  

  • 34. Carboplatin for advanced colorectal carcinoma: a phase II study.
    Perry DJ; Weiss RB; Creekmore SP; Micetich KC; Curt GA
    Cancer Treat Rep; 1986 Feb; 70(2):301-2. PubMed ID: 3512081
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
    Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C
    Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma.
    Harper HD; Kemeny NE; Ahmed T; Cheng E; Arena F; Sordillo P; Faye L
    Cancer Treat Rep; 1984 Apr; 68(4):689-90. PubMed ID: 6585273
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.
    Nichols WC; Kvols LK; Ingle JN; Edmonson JH; Ahmann DL; Rubin J; O'Connell MJ
    Cancer Treat Rep; 1978 May; 62(5):837-9. PubMed ID: 657166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study on oral N-methylformamide in metastatic colorectal cancer.
    Planting AS; Klijn JG; Verweij J; Stoter G
    Cancer Treat Rep; 1987 Dec; 71(12):1293-4. PubMed ID: 3690540
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial.
    Locker GY; Lanzotti V; Sweet D; Lad T; Khandekar J; Stiff P; Johnson C; Miller S
    Cancer Treat Rep; 1984 Oct; 68(10):1303-4. PubMed ID: 6525605
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II evaluation of vindesine in patients with advanced colorectal carcinoma.
    Carroll DS; Gralla RJ; Kemeny NE
    Cancer Treat Rep; 1979; 63(11-12):2097-8. PubMed ID: 526944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.